Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Fulcrum Therapeutics, Inc. FULC

Full chart Compare
Set alert

Price alert · FULC

All alert types
3.76 USD +0.02 (+0.57%)

Nov 4, 2026, 3:21 PM EST

3.73 Day range 3.78
2.83 52-week range 15.74
YTD
-66.74%
1 year
-55.06%

Financial health

Altman Z-Score

10.51 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -9.6×
FY 2017: -9.9×FY 2018: -7.0×FY 2019: -4.8×FY 2020: -4.3×FY 2021: -8.0×FY 2022: -3.1×FY 2023: -4.2×FY 2024: -29.4×FY 2025: -9.6×
FY 2017 5y median -8.0× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 33.7×FY 2021: 32.6×FY 2022: 51.6×FY 2023: 148×FY 2024: 3.6×FY 2025: 0.0×
FY 2017 5y median 32.6× FY 2025
P/B 2.1×
FY 2017: 173×FY 2018: 3.0×FY 2019: 4.3×FY 2020: 3.1×FY 2021: 3.0×FY 2022: 1.6×FY 2023: 1.8×FY 2024: 1.2×FY 2025: 2.1×
FY 2017 5y median 1.8× FY 2025
P/FCF -11.9×
FY 2017: -10.4×FY 2018: -7.3×FY 2019: -9.3×FY 2020: -5.4×FY 2021: -7.8×FY 2022: -3.3×FY 2023: -4.5×FY 2024: -117×FY 2025: -11.9×
FY 2017 5y median -7.8× FY 2025
EV/EBITDA -7.2×
FY 2017: -11.8×FY 2018: -4.8×FY 2019: -3.5×FY 2020: -3.5×FY 2021: -7.5×FY 2022: -2.8×FY 2023: -4.2×FY 2024: -13.3×FY 2025: -7.2×
FY 2017 5y median -7.2× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 27.2×FY 2021: 30.8×FY 2022: 48.2×FY 2023: 142×FY 2024: 3.0×FY 2025: 0.0×
FY 2017 5y median 30.8× FY 2025
FCF Yield -8.4%
FY 2017: -9.6%FY 2018: -13.8%FY 2019: -10.7%FY 2020: -18.5%FY 2021: -12.8%FY 2022: -30.2%FY 2023: -22.1%FY 2024: -0.9%FY 2025: -8.4%
FY 2017 5y median -12.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -569.2%FY 2021: -263.7%FY 2022: -1110.7%FY 2023: -2459.8%FY 2024: 20.8%FY 2025: 0.0%
FY 2017 5y median -263.7% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -811.6%FY 2021: -423.0%FY 2022: -1774.9%FY 2023: -3945.2%FY 2024: -27.4%FY 2025: 0.0%
FY 2017 5y median -423.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -802.7%FY 2021: -421.9%FY 2022: -1732.4%FY 2023: -3470.1%FY 2024: -12.2%FY 2025: 0.0%
FY 2017 5y median -421.9% FY 2025
ROE -21.5%
FY 2017: -1737.1%FY 2018: -42.9%FY 2019: -94.9%FY 2020: -74.4%FY 2021: -38.2%FY 2022: -55.2%FY 2023: -41.4%FY 2024: -4.0%FY 2025: -21.5%
FY 2017 5y median -38.2% FY 2025
ROIC -23.8%
FY 2017: -1478.6%FY 2018: -41.1%FY 2019: -59.6%FY 2020: -69.6%FY 2021: -37.6%FY 2022: -53.0%FY 2023: -44.9%FY 2024: -8.7%FY 2025: -23.8%
FY 2017 5y median -37.6% FY 2025
ROA -20.4%
FY 2017: -529.1%FY 2018: -38.0%FY 2019: -74.9%FY 2020: -54.7%FY 2021: -34.4%FY 2022: -48.5%FY 2023: -37.8%FY 2024: -3.7%FY 2025: -20.4%
FY 2017 5y median -34.4% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 117.2%FY 2022: -66.9%FY 2023: -55.8%FY 2024: 2752.0%FY 2025: -100.0%
FY 2017 FY 2025
Operating Income -287.1%
FY 2017: 0.0%FY 2018: -45.7%FY 2019: -75.0%FY 2020: -22.1%FY 2021: -13.2%FY 2022: -38.9%FY 2023: 1.7%FY 2024: 80.2%FY 2025: -287.1%
FY 2017 FY 2025
EPS (diluted) -637.5%
FY 2017: 0.0%FY 2018: -41.2%FY 2019: -81.8%FY 2020: 22.6%FY 2021: 17.8%FY 2022: -5.9%FY 2023: 32.3%FY 2024: 89.9%FY 2025: -637.5%
FY 2017 FY 2025
Free Cash Flow -2319.0%
FY 2017: 0.0%FY 2018: -43.5%FY 2019: -27.9%FY 2020: -36.3%FY 2021: -45.8%FY 2022: -23.5%FY 2023: 7.6%FY 2024: 97.3%FY 2025: -2319.0%
FY 2017 FY 2025

Financial Health

Current Ratio 27.4×
FY 2017: 0.5×FY 2018: 17.5×FY 2019: 8.2×FY 2020: 4.2×FY 2021: 11.8×FY 2022: 12.4×FY 2023: 17.7×FY 2024: 22.6×FY 2025: 27.4×
FY 2017 5y median 17.7× FY 2025
Quick Ratio 27.4×
FY 2017: 0.2×FY 2018: 17.4×FY 2019: 8.0×FY 2020: 4.3×FY 2021: 11.8×FY 2022: 12.4×FY 2023: 17.7×FY 2024: 22.6×FY 2025: 27.4×
FY 2017 5y median 17.7× FY 2025
Debt / Equity 0.0×
FY 2017: 26.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 2.6×
FY 2017: -1.5×FY 2018: 2.3×FY 2019: 1.2×FY 2020: 0.8×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 2.7×FY 2025: 2.6×
FY 2017 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31